secwatch.observer — SEC 8-K summary
======================================

Issuer:     Traws Pharma, Inc. (TRAW)
CIK:        0001130598
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001104659-25-022193
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Traws Pharma enters ATM equity facility for up to $50M with Citizens JMP Securities
--------------------------------------------------------------------------------

- ATM agreement allows sale of common stock up to $50M aggregate, subject to baby shelf limit of $5,514,200.
- Shares sold at market prices on Nasdaq via Citizens JMP as agent; commission is 3% of gross proceeds.
- Prospectus supplement dated March 10, 2025 filed under Rule 424(b); Company not obligated to sell any shares.
- ATM may be terminated by Company with 5 business days' notice or by Manager at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925022193/0001104659-25-022193-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130598/000110465925022193/tm258583d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-022193

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer